Alaunos Therapeutics (TCRT) Non Operating Income (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Non Operating Income of $6000.0 for Q1 2026, down 68.42% on a YoY basis from $19000.0 in Q1 2025, and down 86.67% quarter-over-quarter from $45000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Non Operating Income (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Non Operating Income for 18 years, with the latest figure at $6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 68.42% year-over-year to $6000.0; the trailing twelve-month figure through Mar 2026 stood at $98000.0 (up 6.52% YoY), and the FY2025 full-year result was $80000.0, down 39.85% from the prior year.
- Non Operating Income for Q1 2026 stood at $6000.0, down from $45000.0 in the prior quarter.
- The five-year high for Non Operating Income was $477000.0 in Q1 2023, with the low at -$703000.0 in Q1 2022.
- Historically, Non Operating Income has averaged $14823.5 across 5 years, with a median of $37000.0 in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income tumbled 7911.11% — and 2023, when it jumped 575.61%.
- Alaunos Therapeutics' Non Operating Income stood at -$638000.0 in 2022, then surged by 116.61% to $106000.0 in 2023, then plunged by 87.74% to $13000.0 in 2024, then soared by 246.15% to $45000.0 in 2025, then slumped by 86.67% to $6000.0 in 2026.
- The last three Non Operating Income figures came in at $6000.0 (Q1 2026), $45000.0 (Q4 2025), and $28000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 60,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 277,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Dec 31, 2022 | -638,000.00 |
| Sep 30, 2022 | 254,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | -703,000.00 |
| Dec 31, 2021 | -743,000.00 |
| Sep 30, 2021 | -437,000.00 |
| Jun 30, 2021 | -31,000.00 |